BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16954654)

  • 1. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E; Strydom K; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbröker D; Bardin PG
    J Allergy Clin Immunol; 2005 Aug; 116(2):292-8. PubMed ID: 16083782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma.
    Bousquet J; Aubier M; Sastre J; Izquierdo JL; Adler LM; Hofbauer P; Rost KD; Harnest U; Kroemer B; Albrecht A; Bredenbröker D
    Allergy; 2006 Jan; 61(1):72-8. PubMed ID: 16364159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of roflumilast in the treatment of asthma.
    Bateman ED; Izquierdo JL; Harnest U; Hofbauer P; Magyar P; Schmid-Wirlitsch C; Leichtl S; Bredenbröker D
    Ann Allergy Asthma Immunol; 2006 May; 96(5):679-86. PubMed ID: 16729780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
    Gauvreau GM; Boulet LP; Schmid-Wirlitsch C; Côté J; Duong M; Killian KJ; Milot J; Deschesnes F; Strinich T; Watson RM; Bredenbröker D; O'Byrne PM
    Respir Res; 2011 Oct; 12(1):140. PubMed ID: 22029856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM; Kusma M; Feuring M; Timmer WE; Neuhäuser M; Bethke T; Stuck BA; Hörmann K; Wehling M
    J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
    Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
    Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen.
    Cockcroft DW; Davis BE; Boulet LP; Deschesnes F; Gauvreau GM; O'Byrne PM; Watson RM
    Allergy; 2005 Jan; 60(1):56-9. PubMed ID: 15575931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness.
    Bentley AM; Walker S; Hanotte F; De Vos C; Durham SR
    Clin Exp Allergy; 1996 Aug; 26(8):909-17. PubMed ID: 8877156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor.
    Bethke TD; Böhmer GM; Hermann R; Hauns B; Fux R; Mörike K; David M; Knoerzer D; Wurst W; Gleiter CH
    J Clin Pharmacol; 2007 Jan; 47(1):26-36. PubMed ID: 17192499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
    Subbarao P; Dorman SC; Rerecich T; Watson RM; Gauvreau GM; O'Byrne PM
    J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast for asthma: Efficacy findings in mechanism of action studies.
    Bardin P; Kanniess F; Gauvreau G; Bredenbröker D; Rabe KF
    Pulm Pharmacol Ther; 2015 Dec; 35 Suppl():S4-10. PubMed ID: 26296794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
    Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
    Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.